Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery.
Publication
, Journal Article
Rao, SV; Ohman, EM
Published in: JAMA
August 9, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
August 9, 2022
Volume
328
Issue
6
Start / End Page
532 / 533
Location
United States
Related Subject Headings
- Risk Assessment
- Platelet Aggregation Inhibitors
- Humans
- General & Internal Medicine
- Coronary Artery Bypass
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rao, S. V., & Ohman, E. M. (2022). Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery. JAMA, 328(6), 532–533. https://doi.org/10.1001/jama.2022.12444
Rao, Sunil V., and E Magnus Ohman. “Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery.” JAMA 328, no. 6 (August 9, 2022): 532–33. https://doi.org/10.1001/jama.2022.12444.
Rao SV, Ohman EM. Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery. JAMA. 2022 Aug 9;328(6):532–3.
Rao, Sunil V., and E. Magnus Ohman. “Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery.” JAMA, vol. 328, no. 6, Aug. 2022, pp. 532–33. Pubmed, doi:10.1001/jama.2022.12444.
Rao SV, Ohman EM. Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery. JAMA. 2022 Aug 9;328(6):532–533.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
August 9, 2022
Volume
328
Issue
6
Start / End Page
532 / 533
Location
United States
Related Subject Headings
- Risk Assessment
- Platelet Aggregation Inhibitors
- Humans
- General & Internal Medicine
- Coronary Artery Bypass
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences